Relay Therapeutics Hopes ‘Safety First’ Approach Will Pay Off For Targeted Breast Cancer Drug

Share Price Tanks After Virtually No Response To Therapy

 
• By Andrew McConaghie
  
Orlando convention center
Relay Therapeutics presented its data at the AACR congress in Orlando, Florida. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D